Catheter Precision, Inc. current report, 10 May 2022

SEC Filing Summary: Ra Medical Systems, Inc. (RMED)

Business Context and Reporting Period

This Form 8-K was filed on May 10, 2022, by Ra Medical Systems, Inc. (not Catheter Precision, Inc., as noted in the metadata request). The report covers two primary events: the announcement of financial results for the three months ended March 31, 2022, and the resignation of the Chief Financial Officer.

Key Financial Metrics

The filing references a press release (Exhibit 99.1) containing the financial results for the quarter ended March 31, 2022. However, the text of this 8-K does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.

Material Changes and Corporate Events

  • Executive Departure: Andrew Jackson, Chief Financial Officer and Secretary, notified the Company on May 10, 2022, of his resignation, effective May 25, 2022.
  • Reason for Departure: The resignation is not the result of any disagreement with the Company or its Board regarding operations, policies, or practices.
  • Separation Agreement: The Company expects to enter into a Separation Agreement with Mr. Jackson, though terms are not yet finalized.

Guidance, Outlook, and Risks

The filing does not contain specific forward-looking guidance, management commentary on future performance, or detailed risk factors within the text provided. The financial results referenced in Item 2.02 are furnished and not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, limiting their incorporation by reference into other documents unless expressly stated.

Key Facts for Investor Verification

  • Verify the specific financial results for the quarter ended March 31, 2022, by reviewing the attached Press Release (Exhibit 99.1), as this 8-K does not list the numbers.
  • Confirm the appointment of an interim or permanent replacement for Andrew Jackson following his May 25, 2022, departure.
  • Review the terms of the pending Separation Agreement with the outgoing CFO once finalized.
  • Note the discrepancy between the metadata company name ("Catheter Precision, Inc.") and the actual registrant ("Ra Medical Systems, Inc.").